 So, Dr. Farid, I turn to you with a perspective from the Emirates and the region. Thank you. It's really a very interesting and very important discussion that we have regarding the global governance and being more prepared to pandemics. I think that there is a lot to be done. There are six main priority areas that we need to focus on, starting from the leadership commitment and I see that the global conversation to revise the governance structure is really going on, but it is slower compared to the risk of having a new global pandemic, which is existing to all of us at the global level, but also at the regional level. I think the Imro region is very unique in terms of the structure. Why disparity of economics? We have major insecurity and political instability in certain areas of our region that really increase the risk of outbreaks and also increase the risk of any future pandemics. So, in terms of leadership commitment, I see that COVID-19 pandemic was a very interesting lesson to the political leadership across the world because of the huge impact not only to the health, but also to the economics and to the political systems across the world. However, we need also to realize that some of the challenges that we face are really constrained for the global community to work together in a collaborative approach. We see, for example, nationalism towards vaccines, which prevented us from good access to different vaccinations. So, in terms of the global governance systems, we need to think of what are the priorities that we need to focus on, and having strong healthcare systems is one of the critical issues. We know and we understand that there are fragile healthcare systems in certain countries and certain regions, but we cannot really afford those systems to affect the global health security in terms of emerging new diseases. So, we need to work together to strengthen those healthcare systems in the minimum requirements in terms of the disease surveillance, in terms of the access to care, and in terms of the vaccination. I think Michael is covered vaccination very comprehensively. I would like to add to that the access to immunotherapies, and this has been really a game-changing during COVID-19. However, we could see that immunotherapies are not affordable because of the high pricing that have been really an issue to many countries. So, it was limited to certain countries who can afford it. So, I think thinking about the global governance and preparedness, immunotherapies should be really part of the priority areas for the discussions in addition to vaccinations, because they are easier in terms of the manufacturing and faster in terms of mobilization and effectiveness for the high-risk affected groups. So, immunotherapies really are a very important part of the discussion. I think also talking about innovation and research is very important because we need to not stop in terms of accelerating research. Time was critical during COVID, and our governance in terms of the research approvals and prioritizations are really very slow that are not matching the global needs. So, we need to talk collectively on how best we can revise the governance systems and revise our research regulations to accelerate research and to align our research priorities to the risks that we have in terms of the global health security to the world. The last point that I would like to cover is related to surveillance, and I believe that we have really historically been working closely at international government to define the surveillance requirements across the globe. However, I think our surveillance needs to be revised in terms of being more comprehensive. We had a lot, many disease-based surveillance systems that are really defined well at the global community, but it's not covering all the risks that we have. So, we need to do a risk assessment in terms of what are the potential risks in terms of the future pandemics and how we can enhance our surveillance systems to be more comprehensive, more integrated, and more adaptive to the new technologies to support our preparedness in the future. Thank you. Thank you. And thank you for bringing the issue of research. We're talking of regionalization and decentralization of manufacturing capacity, but obviously research is an essential component.